内华达州与新墨西哥州尿液毒理学结果与自报芬太尼使用高度一致
该横断面调查于2022年8月至2023年8月在内华达州和新墨西哥州纳入411名过去三个月内报告任何非医疗用药的成人,其中64%(n=270)完成了可检测过去三天芬太尼使用的尿液毒理学筛查。在268名可评估参与者中,146人(54.5%)尿液芬太尼阳性、122人(45.5%)阴性;137人(51.1%)自报过去三天使用芬太尼,130人(48.5%)未自报。尿液阳性者中仅6.9%未自报近期使用芬太尼;自报的敏感性93%、特异性97%、阳性预测值97%、阴性预测值92%。作者认为该样本中非预期芬太尼暴露率低,与国家层面关于药物供应中芬太尼广泛未知污染的叙事相反。
要点
- 在268名可评估参与者中,146人(54.5%)尿液芬太尼阳性,137人(51.1%)自报过去三天使用芬太尼。
- 尿液芬太尼阳性者中仅6.9%未自报近期使用,即非预期暴露率低。
- 自报芬太尼使用对尿液毒理学筛查的敏感性93%、特异性97%、阳性预测值97%、阴性预测值92%。
- 作者认为该结果与国家层面关于药物供应中芬太尼广泛未知污染的叙事相反。
- 作者指出未来研究需进一步探讨多种物质使用者如何理解其过量风险及采取何种减害方法。
适用人群与场景
- 美国内华达州和新墨西哥州过去三个月内报告任何非医疗用药的成人。
- 411名参与者中64%(n=270)完成尿液毒理学筛查,268人纳入描述性统计(2人尿液结果不确定被排除)。
诊断标准与关键阈值
- 自报过去三天芬太尼使用(是/否)。
- 尿液毒理学筛查检测过去三天芬太尼使用(阳性/阴性)。
研究设计与关键结果
- 研究类型为横断面调查,于2022年8月至2023年8月在内华达州和新墨西哥州纳入411名成人,其中270人完成尿液毒理学筛查。
- 268名可评估参与者中,146人(54.5%)尿液芬太尼阳性,122人(45.5%)阴性;137人(51.1%)自报过去三天使用芬太尼,130人(48.5%)未自报。
- 尿液芬太尼阳性者中仅6.9%未自报近期芬太尼使用。
- 自报芬太尼使用的敏感性93%、特异性97%、阳性预测值97%、阴性预测值92%。
证据类型、等级与局限
- 证据类型:横断面调查。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为该样本中非预期芬太尼暴露率低(6.9%),与国家层面关于药物供应中芬太尼广泛未知污染的叙事相反。
- 作者指出未来研究需进一步探讨多种物质使用者如何理解其过量风险及采取何种减害方法。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Co-use of stimulants and opioids is often deliberate. However, the possibility remains that some people are unintentionally consuming fentanyl. To advance understanding of overdose risk, we examined the rate of concordance between self-reported fentanyl use and corresponding urine toxicology screen results.
METHODS: Between August 2022-August 2023, 411 participants (adults who reported any non-medical drug use in the past three months) in Nevada and New Mexico completed a cross-sectional survey, of whom 64% (n = 270; the analytical sample) also completed a urine toxicology screen, which detects fentanyl use in the past three days. Positive predictive value, negative predictive value, sensitivity, and specificity were calculated using self-reported past three-day fentanyl use (yes/no) and urine toxicology screen results for the presence of fentanyl (positive/negative).
RESULTS: Of the 270 participants who provided a urine sample, 268 are included in the descriptive statistics (two with inconclusive urine toxicology screen results were excluded). Of the 268 participants, 146 (54.5%) had a fentanyl-positive urine toxicology screen result, 122 (45.5%) had a fentanyl-negative urine toxicology screen result, 137 (51.1%) reported past three-day fentanyl use, and 130 (48.5%) reported no past three-day fentanyl use. Only 6.9% of those with a fentanyl-positive urine toxicology screen did not report recent fentanyl use. The sensitivity of self-reported fentanyl use was 93%, specificity was 97%, positive predictive value was 97%, and negative predictive value was 92%.
DISCUSSION: The rate of unanticipated exposure to fentanyl (that is, positive urine screen and negative self-report) in this sample was low, at 6.9%. This runs counter to the national narrative that there is widespread unknown contamination of fentanyl in the drug supply.
CONCLUSION: Future research is needed to further explore how people who use multiple substances interpret their overdose risk and what harm reduction methods they employ.
参考来源
- Kirk MR, McCarthy M, Reyes A, et al. High concordance between urine toxicology results and self-reported fentanyl use in Nevada and New Mexico. Clin Toxicol (Phila). 2024. PMID: 39230064. doi:10.1080/15563650.2024.2391011
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。